NTRK2 and breast cancer: A study of NTRK2 and anoikis in breast cancer cell lines also showed that miR-200c can directly target neurotrophin 3 (NTF3) and this NTRK2/NTF3 signaling is the downstream effector of NFKB signaling which promotes anoikis (Howe et al., 2012).